UCB (PK) Quote - UCBJY

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

98.57

Bid

98.03

Offer

100.79

Volume

11,144

98.57 Day's Range 100.03

44.26 52 Week Range 100.43

Market Cap

37.377B

Previous Close

98.405

Open

99.57

Last Trade

98.87

Last Trade Time

Financial Volume

US$ 1,103,240

VWAP

98.9986

Average Volume (3m)

17,546

Shares Outstanding

379,189,796

Dividend Yield

0.94%

PE Ratio

211.36

Earnings Per Share (EPS)

0.9

Revenue

4.87B

Net Profit

343M

UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector

Pharmaceutical Preparations

Industry

Chemicals & Allied Products

Website

www.ucb.com

Headquarters

Brussels, Brussels-capital Region, Bel

Founded

1928

UCB (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker UCBJY. The last closing price for UCB (PK) was US$98.41. Over the last year, UCB (PK) shares have traded in a share price range of US$ 44.26 to US$ 100.43.

UCB (PK) currently has 379,189,796 shares in issue. The market capitalisation of UCB (PK) is US$37.31 billion. UCB (PK) has a price to earnings ratio (PE ratio) of 211.36.

UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services

UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services Judges highlight value-added partnership and finance transformation as leading examples of innovation in...

New Data Identify Important Factors that May Reduce Hospitalizations among People with Epilepsy in the U.S.

New Data Identify Important Factors that May Reduce Hospitalizations among People with Epilepsy in the U.S. Results of retrospective analysis show use of newer anti-epilepsy drugs, access to...

UCB Announces Crohn's Disease Data to be Presented at Digestive Disease Week 2015

UCB Announces Crohn's Disease Data to be Presented at Digestive Disease Week 2015 PR Newswire ATLANTA, May 16, 2015 ATLANTA, May 16, 2015 /PRNewswire/ -- UCB, a global biopharmaceutical company...

UCB announces US and EU regulatory filings for the investigational antiepileptic drug brivaracetam

UCB announces US and EU regulatory filings for the investigational antiepileptic drug brivaracetam - Major milestone for brivaracetam is latest step towards UCB goal of extending treatment...

UCB and Emory Present New Assessment of Epilepsy Prevalence and Incidence in the U.S. at 2014 American Epilepsy Society Annua...

UCB and Emory Present New Assessment of Epilepsy Prevalence and Incidence in the U.S. at 2014 American Epilepsy Society Annual Meeting PR Newswire ATLANTA, Dec. 8, 2014 ATLANTA, Dec. 8, 2014...

UCB announces first presentation of primary data from latest Phase 3 study evaluating brivaracetam as adjunctive treatment of...

UCB announces first presentation of primary data from latest Phase 3 study evaluating brivaracetam as adjunctive treatment of partial-onset seizures in epilepsy -- Primary efficacy and safety...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.23	-0.232793522267	98.8	100.03	97.66	8276	98.27258723	DR
4	3.24	3.39872023497	95.33	100.43	94.206	7445	97.31071414	DR
12	4.18	4.42843521559	94.39	100.43	86.71	17546	95.43837914	DR
26	21.505	27.9050152469	77.065	100.43	74.55	16140	90.68658479	DR
52	53.22	117.353914002	45.35	100.43	44.26	17467	76.11145213	DR
156	44.27	81.5285451197	54.3	100.43	32.82	20906	51.2963137	DR
260	55.25	127.539242844	43.32	100.43	32.45	20023	52.56127729	DR

UCBJY - Frequently Asked Questions (FAQ)

What is the current UCB (PK) share price?

The current share price of UCB (PK) is US$ 98.57

How many UCB (PK) shares are in issue?

UCB (PK) has 379,189,796 shares in issue

What is the market cap of UCB (PK)?

The market capitalisation of UCB (PK) is USD 37.31B

What is the 1 year trading range for UCB (PK) share price?

UCB (PK) has traded in the range of US$ 44.26 to US$ 100.43 during the past year

What is the PE ratio of UCB (PK)?

The price to earnings ratio of UCB (PK) is 211.36

What is the cash to sales ratio of UCB (PK)?

The cash to sales ratio of UCB (PK) is 14.9

What is the reporting currency for UCB (PK)?

UCB (PK) reports financial results in EUR

What is the latest annual turnover for UCB (PK)?

The latest annual turnover of UCB (PK) is EUR 4.87B

What is the latest annual profit for UCB (PK)?

The latest annual profit of UCB (PK) is EUR 343M

What is the registered address of UCB (PK)?

The registered address for UCB (PK) is 60, ALLEE DE LA RECHERCHE, BRUSSELS, BRUSSELS-CAPITAL REGION, B-1070

What is the UCB (PK) website address?

The website address for UCB (PK) is www.ucb.com

Which industry sector does UCB (PK) operate in?

UCB (PK) operates in the CHEMICALS & ALLIED PRODUCTS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc (CE)	US$ 0.008 (799,900.00%)	477
VENGVision Energy Corporation (CE)	US$ 0.0005 (49,900.00%)	10.5k
PLFXPulse Evolution Corporation (CE)	US$ 0.0003 (29,900.00%)	530
EATREastern Asteria Inc (CE)	US$ 0.0003 (29,900.00%)	9.35M
RBSHRebus Holdings Inc (CE)	US$ 0.0001 (9,900.00%)	402
FPWMCharlestowne Premium Beverages Inc (CE)	US$ 0.000001 (-100.00%)	1,000
ZHCLFZenith Capital Corporation (CE)	US$ 0.0001 (-99.86%)	7.95k
CRGPCalissio Resources Group Inc (CE)	US$ 0.000001 (-99.75%)	28k
NEOMNeoMedia Technologies Inc (CE)	US$ 0.000001 (-99.50%)	114.32k
DOCKFBeyond Med Technologies Inc (PK)	US$ 0.0001 (-99.50%)	745
AITXArtificial Intelligence Technology Solutions Inc (PK)	US$ 0.004 (-13.04%)	331.01M
HMBLHUMBL Inc (PK)	US$ 0.00085 (-5.56%)	288.72M
GRLFGreen Leaf Innovations Inc (PK)	US$ 0.0001 (-50.00%)	250.92M
TKMOTekumo Inc (PK)	US$ 0.0003 (0.00%)	201.65M
ASIIAccredited Solutions Inc (PK)	US$ 0.0007 (40.00%)	192.43M